Your session is about to expire
← Back to Search
Artificial Intelligence
AI-Based Fall Detection for Alzheimer's Disease
N/A
Waitlist Available
Research Sponsored by SafelyYou
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up data will be collected during year 1 and assessed at the end of year 1.
Awards & highlights
Summary
This trial will study if the SafelyYou system can detect falls and provide better support for people with dementia who live in long-term care facilities.
Who is the study for?
This trial is for adults with Alzheimer's Disease who live in a participating skilled nursing facility or continuing care retirement community. It aims to help those at risk of falls due to dementia. People under the age of 18 cannot participate.
What is being tested?
The SafelyYou Fall Prevention System, which uses AI-enabled cameras to detect and alert staff about fall events in real-time, is being tested for its effectiveness in preventing injuries from unwitnessed falls among dementia patients.
What are the potential side effects?
Since this trial involves a monitoring system rather than medication, traditional side effects are not expected. However, there may be concerns related to privacy due to video surveillance.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ data will be collected during year 1 and assessed at the end of year 1.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~data will be collected during year 1 and assessed at the end of year 1.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Enrollment rate
Fall rate due to gait change detection
Fall rate due to sit to stand transition detection
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
AI-enabled camera fall detection with Human-in-the-Loop (HIP) review
Group II: ControlActive Control1 Intervention
No camera detection
Find a Location
Who is running the clinical trial?
SafelyYouLead Sponsor
1 Previous Clinical Trials
300 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,543 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger